Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Global Evaluation of the Antibacterial Activity of Ceftolozane/Tazobactam Against Esbls-Producing Escherichia Coli and Klebsiella Pneumoniae: A Systematic Review and Meta-Analysis Publisher



Rahim Khorasani M1 ; Rostami S2 ; Bakhshi A3 ; Sheikhi R4
Authors

Source: Therapeutic Advances in Infectious Disease Published:2023


Abstract

Background: Ceftolozane/Tazobactam is a β-lactam/β-lactamase inhibitor combination with a high range of efficacy and broad-spectrum action against multidrug-resistant bacterial strains. Objectives: The present study aimed to analyze the in vitro activity of Ceftolozane/Tazobactam against extended-spectrum β-lactamases (ESBLs)-producing Escherichia coli (ESBLs-EC) and Klebsiella pneumonia (ESBLs-KP) in the published literature to provide international data on the antimicrobial stewardship programs. Design: Systematic review and meta-analysis. Methods: A systematic literature search was conducted on the Web of Science, Embase, PubMed, Scopus, and Google Scholar electronic databases from the beginning of databases to December 2022 to cover all published articles relevant to our scope. Results: At last, 31 publications that met our inclusion criteria were selected for data extraction and analysis by Comprehensive Meta-Analysis Software. The pooled prevalence of Ceftolozane/Tazobactam susceptibility for ESBLs-EC and ESBLs-KP was estimated at 91.3% [95% confidence interval (CI): 90.1–92.5%] and 65.6% (95% CI: 60.8–70.2%), respectively. There was significant heterogeneity among the 31 studies for ESBLs-EC (χ2 = 91.621; p < 0.001; I2 = 67.256%) and ESBLs-KP (χ2 = 348.72; p < 0.001; I2 = 91.4%). Most clinical isolates of ESBLs-EC had MIC50 and MIC90 at a concentration of 0.5 and 2 µg/mL [minimum inhibitory concentration (MIC) at which 50% and 90% of isolates were inhibited], respectively. In contrast, most clinical isolates of ESBLs-KP had MIC50 and MIC90 at a concentration of 1 and 32 µg/mL, respectively. Conclusion: Based on the meta-analysis results, Ceftolozane/Tazobactam has a more promising in vitro antibacterial activity against ESBLs-EC isolates from different clinical sources than ESBLs-KP isolates. Therefore, Ceftolozane/Tazobactam can be a useful therapeutic drug as an alternative to carbapenems. Randomized clinical trials are needed to provide clinical evidence to support these observations. © The Author(s), 2023.
Related Docs
View other Related Docs
1. Identification of Beta-Lactamase-Producing Pseudomonas Aeruginosa With Multiple Antibiotic Resistances, Journal of Isfahan Medical School (2011)
2. Prevalence of Blactx-M Gene Among Extended-Spectrum Β-Lactamases Producing Klebsiella Pneumoniae Clinical Isolates in Iran: A Meta-Analysis, Iranian Journal of Medical Sciences (2018)
3. Investigation of Ndm Metallo-Beta-Lactamase and Cmy-2 Ampc Β-Lactamase Production in Escherichia Coli and Enterobacter Spp. Isolated From Human, Comparative Clinical Pathology (2018)
Experts (# of related papers)
View all Related Experts
Hossein Fazeli (3)
Jamshid Faghri (3)
Other Related Docs
4. Global Resistance of Imipenem/Relebactam Against Gram-Negative Bacilli: Systematic Review and Meta-Analysis, Current Therapeutic Research - Clinical and Experimental (2024)
5. Prevalence and Antibiotic Resistance Pattern of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli in Clinical Specimens, Journal of Research in Medical Sciences (2019)
6. Frequency Assessment of Β-Lactamase Enzymes in Escherichia Coli and Klebsiella Isolates in Patients With Urinary Tract Infection, Journal of Research in Medical Sciences (2014)
7. Detection of New Delhi Metallo-Beta-Lactamase-1 (Ndm-1) in Carbapenem-Resistant Klebsiella Pneumoniae Isolated From a University Hospital in Iran, Hippokratia (2015)
8. Emergence of Cefepime Resistance in Gram-Negative Induced Nosocomial Infections, Iranian Journal of Clinical Infectious Diseases (2009)
9. Resistotyping, Phenotyping and Genotyping of New Delhi Metallo-Β-Lactamase (Ndm) Among Gram-Negative Bacilli From Iranian Patients, Journal of Medical Microbiology (2017)
10. Prevalence of Ctx-M Genes in Escherichia Coli Strains in Outpatient and Inpatient Cases With Urinary Tract Infections in Isfahan, Iran, Journal of Isfahan Medical School (2016)
11. Phenotypic and Molecular Characterization of Extended-Spectrum Β-Lactamase Produced by Escherichia Coli, and Klebsiella Pneumoniae Isolates in an Educational Hospital, Jundishapur Journal of Microbiology (2014)
12. Identification of Blaoxa−51−23−58, Blavim, Blandm, and Blaimp Carbapenemase Genes in Acinetobacter Baumannii Isolates From Hospitalized Patients, BMC Research Notes (2024)
13. The Emergence of Blaoxa-48 and Blandm Among Esbl-Producing Klebsiella Pneumoniae in Clinical Isolates of a Tertiary Hospital in Iran, Acta Microbiologica et Immunologica Hungarica (2018)
14. Considerable Rate of Putative Virulent Phylo-Groups in Fecal Carriage of Extended-Spectrum Β-Lactamase Producing Escherichia Coli, Infection, Genetics and Evolution (2019)
15. Detection of Blactx-M15 and Blaoxa-48 Genes in Gram-Negative Isolates From Neonatal Sepsis in Central of Iran, Iranian Journal of Microbiology (2019)
16. High Rate of Carbapenem-Resistant Klebsiella Pneumoniae Detected From Hospital Equipments in Iran, Acta Microbiologica et Immunologica Hungarica (2018)
17. Design, Synthesis, and Antibacterial Activity of Novel Carbacephems, Letters in Drug Design and Discovery (2006)
18. Emergence of Bla-Ctx-M-Type Gene in Salmonella Enterica Serotypes Isolated From Patients Stool, Journal of Isfahan Medical School (2011)
19. Resistance to Colistin and Detection of Mcr-1 Gene in Multidrug-Resistant Pseudomonas Aeruginosa Isolated From Wounds of the Hospitalized Burned Patients, Journal of Isfahan Medical School (2022)
20. Frequency Determination of Carbapenem-Resistant Klebsiella Pneumoniae (Crkp) Isolated From Hospitals in Isfahan of Iran and Evaluation of Synergistic Effect of Colistin and Meropenem on Them, Cellular and Molecular Biology (2018)